| Identification | Back Directory | [Name]
1H-Pyrazole-4-carboxamide, N-[(6-amino-2,4-dimethyl-3-pyridinyl)methyl]-1-[(4-methoxyphenyl)methyl]- | [CAS]
1357950-47-0 | [Synonyms]
Plasma kallikrein-IN-3
1H-Pyrazole-4-carboxamide, N-[(6-amino-2,4-dimethyl-3-pyridinyl)methyl]-1-[(4-methoxyphenyl)methyl]- | [Molecular Formula]
C20H23N5O2 | [MOL File]
1357950-47-0.mol | [Molecular Weight]
365.43 |
| Hazard Information | Back Directory | [Uses]
Plasma kallikrein-IN-3 is a plasma kallikrein inhibitor (IC50: 0.15 μM). Plasma kallikrein-IN-3 can be used for hereditary angioedema, diabetic macular edema, and diabetic retinopathy research[1]. | [References]
[1] Brandl Trixi, et al. Preparation of N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides as inhibitors of plasma kallikrein. Patent WO2012017020. |
|
|